Innovating Works

CTCM

A stranger
CARDIATEAM: CARdiomyopathy in type 2 DIAbetes mellitus CLINICAL TRIAL CENTER MAASTRICHT participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage A rapidly evolving epidemic in Type 2 Diabetes (T2DM) is afflicting all ages, sexes and socioeconomic classes which includes serious comorbi...
2019-04-11 - 2026-02-28 | financed
IMMUNOSABR: Clinical proof of concept through a randomised phase II study a combination of immunotherapy and st... CLINICAL TRIAL CENTER MAASTRICHT participó en un H2020: H2020-SC1-2016-2017 IMMUNOSABR is geared towards opening up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-m...
2016-12-12 - 2024-12-31 | financed
ECRIN-IA: European Clinical Research Infrastructures Network Integrating Activity ECRIN is a distributed ESFRI-roadmap pan-European infrastructure designed to support multinational clinical research, making Europe a single...
financed
BM4SIT: AN INNOVATIVE CAUSAL THERAPY FOR ALLERGY SAFE AND RAPID INDUCTION OF AN ANTI INFLAMMATORY IMMUNE RE... CLINICAL TRIAL CENTER MAASTRICHT participó en un FP7: Allergy is the most prevalent chronic inflammatory disease, having great socio-economic impact. Chronic lifelong dependency on symptomatic d...
financed
FAST: TOWARDS SAFE AND EFFECTIVE IMMUNOTHERAPY OF PERSISTENT LIFE THREATENING FOOD ALLERGIES CLINICAL TRIAL CENTER MAASTRICHT participó en un FP7: The FAST project aims at the development of safe and effective treatment of food allergies. It targets persistent and severe allergy to fish...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.